Application of circulating tumor cells detection in non-small cell lung cancer

Abstract

LI Hao-；Li-Sheng-；Zhang-Bai-Jiang. Application of circulating tumor cells detection in non-small cell lung cancer[J]. Journal of International Oncology, 2015, 42(4): 298-300.

［1］ Siegel R, Naishadham D, Jemal A. Cancer statistics,2012［J］. CA Cancer J Clin, 2012,62(1): 1029. ［2］ Mazzone P, Mekhail T. Current and emerging medical treatments for nonsmall cell lung cancer: a primer for pulmonologists［J］. Respir Med, 2012,106(4): 473492. ［3］ Hou JM, Krebs M, Ward T, et al. Circulating tumor cells as a window on metastasis biology in lung cancer［J］. Am J Pathol, 2011, 178(3): 989996. ［4］ Duda DG, Ancukiewicz M, Isakoff SJ, et al. Seeds and soil: unraveling the role of local tumor stroma in distant metastasis［J］. J Natl Cancer Inst, 2014, 106(8): dju187. ［5］ Krebs MG, Metcalf RL, Carter L, et al. Molecular analysis of circulating tumour cellsbiology and biomarkers［J］. Nat Rev Clin Oncol, 2014, 11(3): 129144. ［6］ Burki TK. Late detection of lung cancer［J］. Lancet Oncol, 2014, 15(13): e590. ［7］ Ilie M, Hofman V, LongMira E, et al. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease［J］. PLoS One, 2014, 9(10): e111597. ［8］ Harouaka RA, Zhou MD, Yeh YT, et al. Flexible micro spring array device for highthroughput enrichment of viable circulating tumor cells［J］. Clin Chem, 2014, 60(2): 323333. ［9］ Weight RM, Viator JA. Detection of circulating tumor cells by photoacoustic flowmetry［J］. Methods Mol Biol, 2014, 1102: 655663. ［10］ Li Q, Qi H, Zhou HX, et al. Detection of micrometastases in peripheral blood of nonsmall cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay［J］. Int J Nanomedicine, 2011, 6: 21752181. ［11］ Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with nonsmallcell lung cancer［J］. J Clin Oncol, 2011, 29(12): 15561563. ［12］ Li J, Shi SB, Shi WL, et al. LUNX mRNApositive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer［J］. Transl Res, 2014, 163(1): 2735. ［13］ Hofman V, Bonnetaud C, Ilie MI, et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker［J］. Clin Cancer Res, 2011, 17(4): 827835.. ［14］ Zhu WF, Li J, Yu LC, et al. Prognostic value of EpCAM/MUC1 mRNApositive cells in nonsmall cell lung cancer patients［J］. Tumour Biol, 2014, 35(2): 12111219. ［15］ Du YJ, Li J, Zhu WF, et al. Survivin mRNAcirculating tumor cells predict treatment efficacy of chemotherapy and survival for advanced nonsmall cell lung cancer patients［J］. Tumour Biol, 2014, 35(5): 44994507. ［16］ Juan O, Vidal J, Gisbert R, et al. Prognostic significance of circulating tumor cells in advanced nonsmall cell lung cancer patients treated with docetaxel and gemcitabine［J］. Clin Transl Oncol, 2014, 16(7): 637643. ［17］ Dorsey JF, Kao GD, MacArthur KM, et al. Tracking viable circulating tumor cells (CTCs) in the peripheral blood of nonsmall cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: Pilot study results［J］. Cancer, 2015, 121(1): 139149. ［18］ Punnoose EA, Atwal S, Liu W, et al. Evaluation of circulating tumor cells and circulating tumor DNA in nonsmall cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib［J］. Clin Cancer Res, 2012, 18(8): 23912401. ［19］ Hashimoto M, Tanaka F, Yoneda K, et al. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer［J］. Interact Cardiovasc Thorac Surg, 2014, 18(6): 775783. ［20］ Yu M, Bardia A, Aceto N, et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility［J］. Science, 2014, 345(6193): 216220. ［21］ Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition［J］. Science, 2013, 339(6119): 580584. ［22］ Comen E, Norton L, Massagué J. Clinical implications of cancer selfseeding［J］. Nat Rev Clin Oncol, 2011, 8(6): 369377. ［23］ Marchetti A, Del Grammastro M, Felicioni L, et al. Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a realtime liquid biopsy for treatment［J］. PLoS One, 2014, 9(8): e103883. ［24］ Pailler E, Adam J, Barthelemy A, et al. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALKpositive nonsmallcell lung cancer［J］. J Clin Oncol, 2013, 31(18):22732281.

Application of circulating tumor cells detection in non-small cell lung cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles0

Recommended Articles

Metrics

Comments